Table 2.
Trends in resistance to quinolones, cefotaxime, cefepime, MDR and ACSSuT pattern among iNTS isolates during the study period
| Period of isolation | No.(%) susceptiblea | No. (%) MDRb | No. (%) CIPR | No. (%) NAR | No. (%) CTXR | No. (%) CFPR | No. (%) ACSSuT | Year isolation no. |
|---|---|---|---|---|---|---|---|---|
| 2007 | 0 | 8 (80) | 0 | 4 (40) | 0 | 0 | 0 | 10 |
| 2008 | 1 (16.7) | 4 (66.7) | 0 | 2 (33.3) | 0 | 0 | 0 | 6 |
| 2009 | 2 (20) | 7 (70) | 0 | 5 (50) | 0 | 0 | 0 | 10 |
| 2010 | 2 (13.3) | 11 (73.3) | 2 (13.3) | 8 (53.3) | 0 | 0 | 0 | 15 |
| 2011 | 2 (10) | 13 (65) | 4 (20) | 14 (70) | 0 | 0 | 0 | 20 |
| 2012 | 2 (14.3) | 8 (57.1) | 2 (14.3) | 9 (64.3) | 2 (14.3) | 0 | 0 | 14 |
| 2013 | 2 (8.3) | 13 (54.2) | 4 (16.7) | 16 (66.7) | 3 (12.5) | 0 | 0 | 24 |
| 2014 | 4 (18.2) | 11 (50) | 4 (18.2) | 15 (68.2) | 3 (13.6) | 0 | 2 (9.1) | 22 |
| 2015 | 2 (9.5) | 9 (42.9) | 4 (19) | 14 (66.7) | 2 (9.5) | 1 (4.8) | 1 (4.8) | 21 |
| 2016 | 4 (11.1) | 11 (30.6) | 7 (19.4) | 27 (75) | 5 (13.9) | 2 (5.6) | 4 (11.1) | 36 |
| Total | 21 (11.9) | 95 (53.4) | 27 (15.2) | 114 (64) | 15 (8.4) | 3 (1.7) | 7 (3.9) | 178 |
Abbreviations: susceptiblea, susceptible to all tested antibiotics; MDRb, resistance to three or more antimicrobial classes; CIPR, ciprofloxacin resistant; NAR, nalidixic acid resistant; CTXR, cefotaxime resistant; CFPR, cefepime resistant; ACSSuT, resistance to tetracycline, sulfamethoxazole, streptomycin, chloramphenicol and ampicillin.